Filtrer vos résultats
- 3
- 3
- 3
- 1
- 1
- 1
- 3
- 3
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
triés par
|
|
Epidemiological landscape of young patients with multiple myeloma diagnosed before 40 years of age: the French experienceBlood, 2021, 138 (25), pp.2686-2695. ⟨10.1182/blood.2021011285⟩
Article dans une revue
hal-03578209v1
|
||
|
Anti-Infectious Pathogen Specificity of Purified Monoclonal Immunoglobulins from Patients with MGUS and Multiple MyelomaBlood, 2016, 128 (22), ⟨10.1182/blood.V128.22.4413.4413⟩
Article dans une revue
hal-03584603v1
|
||
|
Non-interventional Study Evaluating the Mobilization of Stem Cells by Plerixafor Before Salvage Autologous Stem Cell Transplant in Relapsed Multiple Myeloma (IFM-2015-03)Clinical Hematology International, 2023, ⟨10.1007/s44228-023-00030-0⟩
Article dans une revue
hal-03992441v1
|